Delivery Order SPE2DB24D1104-SPE2DB25FYDD6

Award Date 7/11/25
Potential Completion Date 7/14/25
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $6,081.82. The contract is a firm fixed-price delivery order and is not set-aside. The period of performance extends through May 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $4,037.20 and a performance period through June 6, 2025. The contract is not set aside for any special designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $4,926.42 and a period of performance through May 19, 2025. This contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a firm fixed price ceiling value of $24,106.78. The contract has an ultimate completion date of July 3, 2025. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $5,241.50 and an ultimate completion date of May 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, at a firm fixed price of $6,693.65. The contract has a period of performance ending on May 22, 2025. This delivery order is not set aside for any special program. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 60 mg/3 ml DUROLANE syringes, a medical product used for joint pain relief. The contract has a ceiling value of $10,177.08 and a period of performance ending on May 23, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $8,018.42 and a period of performance through March 27, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product. The contract has a ceiling value of $7,010.65 and a performance period ending on April 29, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $4,080.10. The contract has an ultimate completion date of March 5, 2025 and is a firm fixed price contract. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FYDD6
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $5,902.80 and a performance period ending on July 14, 2025. The contract is a firm-fixed price delivery order, with no set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support various government agencies, including the Defense Health Agency and U.S. Coast Guard.

Generated 10/12/25, 12:49 AM